A REVIEW OF THE CURRENT STATUS AND PROSPECTS OF NANOTECHNOLOGY IN THE ADVANCEMENT OF CANCER THERAPY
DOI:
https://doi.org/10.71146/kjmr555Keywords:
Nanotechnology, melanoma, dendrimers, biocompatibility, passive targeting, increased permeability retention (EPR)Abstract
Therapy for melanoma, a type of skin cancer, is very challenging due to its tumor microenvironment, resistance, and spread. Advances in nanotechnology have led to the creation of nanocarriers, which decrease systemic toxicity and increase drug delivery precision. These tools address problems like poor tumor penetration and drug resistance. However, there are still problems with regulatory approval processes, manufacturing scalability, and biocompatibility. Continuous interdisciplinary research is necessary to translate scientific discoveries into therapeutic treatment.
Downloads
Download data is not yet available.
Downloads
Published
2025-07-30
Issue
Section
Health Sciences
License
Copyright (c) 2025 Mehwish Nisar, Sidra Siddiqui, Sarah Jameel Khan (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
A REVIEW OF THE CURRENT STATUS AND PROSPECTS OF NANOTECHNOLOGY IN THE ADVANCEMENT OF CANCER THERAPY. (2025). Kashf Journal of Multidisciplinary Research, 2(07), 133-152. https://doi.org/10.71146/kjmr555
